IP Library Granted Patent US 10,617,787
Granted Patent B2
US 10,617,787 · App. 16/152,963 · Granted Apr 14, 2020

Biopolymer compositions, scaffolds and devices

Inventors: Michael Francis (Norfolk, VA); Nathan Kemper (Norfolk, VA); Hilary Wriggers (Norfolk, VA)
Assignee: EMBODY INC.
A61L27/18A61K9/0024A61K38/39A61K47/34A61L27/24A61L27/26A61L27/3804A61L27/386A61L27/44A61L27/54A61L27/58A61L2300/604A61L2300/64A61L2400/12A61L2430/10A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,617,787
App. No.
16/152,963
Granted
Apr 14, 2020
Kind
B2
Abstract

Compositions and blends of biopolymers and copolymers are described, along with their use to prepare biocompatible scaffolds and surgically implantable devices for use in supporting and facilitating the repair of soft tissue injuries.

Claims (15)

1. An implantable ligament and tendon repair device comprising

an annealed biopolymer sheet having substantially aligned electrospun biopolymer fibers;

wherein the biopolymer fibers comprise about 20 to 35% by weight of Type I collagen and about 65 to 80% by weight of PDLLA having an average molecular weight of about 300,000 to about 600,000 Daltons;

wherein the biopolymer fibers are not cross-linked: and

wherein the biopolymer sheet of the ligament and tendon repair device exhibits one or more of the characteristics selected from the group consisting of:

(i) a range of tensile strength of about 4 to 16 MPa,

(ii) a modulus of elasticity of about 35 to 750 MPa,

(iii) a peak stress of about 11 to 15.2 MPa,

(iv) a strain to failure of 50-200% (0.5 to 2.0 mm/mm) as tensile tested at 1 mm/s in hydrated condition, and

(v) the biopolymer fibers of the biopolymer sheet have an average diameter of about 700 nm to about 1,500 nm.

2. The implantable ligament and tendon repair device of claim 1 , wherein the Type I collagen is selected from the group consisting of atelocollagen, telocollagen, recombinant human collagen and mixtures thereof.

3. The implantable ligament and tendon repair device of claim 2 , wherein the biopolymer sheet has a thickness of about 0.2 mm or about 0.4 mm.

4. The implantable ligament and tendon repair device of claim 1 , wherein the biopolymer fibers of the biopolymer sheet have an average diameter of 700 nm to 1,500 nm.

5. The implantable ligament and tendon repair device of claim 1 , in a form selected from the group consisting of a wrap and an onlay.

6. The implantable ligament and tendon repair device of claim 1 , comprising more than one biopolymer sheet.

Assignments (4)
SECURITY INTEREST Recorded Sep 2, 2021
From: EMBODY, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 057372/0332 →
SECURITY INTEREST Recorded Feb 11, 2021
From: EMBODY, INC.
To: SILICON VALLEY BANK
Reel/Frame 055238/0315 →
ENTITY CONVERSION Recorded Feb 11, 2020
From: EMBODY LLC
To: EMBODY INC.
Reel/Frame 051894/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2018
From: FRANCIS, MICHAEL; KEMPER, NATHAN; WRIGGERS, HILARY
To: EMBODY LLC
Reel/Frame 047486/0569 →
Continuity (3)
Continuation PCTUS2018000119 · May 15, 2018
Provisional Application 62603026 · May 16, 2017
Related Publication 20190054205A1 · Feb 21, 2019
Cited By (3)
US 12,201,748 US 12,324,577 US 12,491,287